Cell Source's Unattributed Round

Cell Source raised a round of funding on December 20, 2013.

Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. The company's "Veto-Cell" technology represents a breakthrough in immu…

Articles about Cell Source's Unattributed Round: